-
Loading metrics
Open Access
Peer-reviewed
Research Article
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis
-
Seth G Thacker,
Roles Investigation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
⨯ -
Ian L. McWilliams,
Roles Investigation
Affiliation Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
⨯ -
Beatrice Bonnet,
Roles Funding acquisition, Project administration, Writing – review & editing
Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯ -
Lydia Halie,
Roles Conceptualization, Investigation
Affiliation Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
⨯ -
Serge Beaucage,
Roles Conceptualization, Writing – review & editing
Affiliation Laboratory of Biological Chemistry; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
⨯ -
Swaksha Rachuri,
Roles Investigation
Affiliation Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
⨯ -
Ranadhir Dey,
Roles Investigation, Methodology
Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
⨯ -
Robert Duncan,
Roles Conceptualization, Writing – review & editing
Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
⨯ -
Farrokh Modabber,
Roles Conceptualization, Writing – review & editing
Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯ - Stephen Robinson,
-
Graeme Bilbe,
Roles Conceptualization, Writing – review & editing
Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯ -
Byron Arana ,
Roles Conceptualization, Writing – review & editing
* E-mail: barana@dndi.org (BA); Daniela.Verthelyi@fda.hhs.gov (DV)
Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯ -
Daniela Verthelyi
Roles Conceptualization, Methodology, Supervision, Writing – original draft, Writing – review & editing
* E-mail: barana@dndi.org (BA); Daniela.Verthelyi@fda.hhs.gov (DV)
Affiliation Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America
⨯
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis
- Seth G Thacker,
- Ian L. McWilliams,
- Beatrice Bonnet,
- Lydia Halie,
- Serge Beaucage,
- Swaksha Rachuri,
- Ranadhir Dey,
- Robert Duncan,
- Farrokh Modabber,
- Stephen Robinson
-
- Published: February 28, 2020
- https://doi.org/10.1371/journal.pntd.0008050